Salona Global Medical Device Corporation
Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York.
Salona Global Medical Device Corporation (LNDZF) - Net Assets
Latest net assets as of September 2024: $-3.43 Million USD
Based on the latest financial reports, Salona Global Medical Device Corporation (LNDZF) has net assets worth $-3.43 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($35.13 Million) and total liabilities ($38.56 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-3.43 Million |
| % of Total Assets | -9.76% |
| Annual Growth Rate | 33.37% |
| 5-Year Change | -69.56% |
| 10-Year Change | -64.3% |
| Growth Volatility | 765.53 |
Salona Global Medical Device Corporation - Net Assets Trend (2013–2024)
This chart illustrates how Salona Global Medical Device Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Salona Global Medical Device Corporation (2013–2024)
The table below shows the annual net assets of Salona Global Medical Device Corporation from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-02-29 | $4.00 Million | 0.00% |
| 2023-12-31 | $4.00 Million | -73.89% |
| 2023-02-28 | $15.33 Million | 0.00% |
| 2022-12-31 | $15.33 Million | +16.56% |
| 2022-02-28 | $13.15 Million | 0.00% |
| 2021-12-31 | $13.15 Million | +98.04% |
| 2021-02-28 | $6.64 Million | 0.00% |
| 2020-12-31 | $6.64 Million | -25.92% |
| 2019-12-31 | $8.97 Million | -20.04% |
| 2018-12-31 | $11.21 Million | +1.57% |
| 2017-12-31 | $11.04 Million | -43.88% |
| 2016-12-31 | $19.67 Million | -33.05% |
| 2015-12-31 | $29.38 Million | +346.31% |
| 2014-12-31 | $6.58 Million | +2968.56% |
| 2013-12-31 | $214.51K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Salona Global Medical Device Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6484371400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (February 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $53.51 Million | 1336.72% |
| Other Comprehensive Income | $2.21 Million | 55.20% |
| Other Components | $13.15 Million | 328.37% |
| Total Equity | $4.00 Million | 100.00% |
Salona Global Medical Device Corporation Competitors by Market Cap
The table below lists competitors of Salona Global Medical Device Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
RightBridge Ventures Group AB
ST:RIGHTB
|
$215.80K |
|
Heart Test Laboratories Inc. Warrant
NASDAQ:HSCSW
|
$215.99K |
|
NRSA
STU:NRSA
|
$216.06K |
|
AJ Bell plc
LSE:AJB
|
$216.16K |
|
National Rural Utilities Cooperative Finance Corp
NYSE:NRUC
|
$215.55K |
|
TRINITY IND
BE:TTA
|
$215.50K |
|
Wealth Inv OptiAct and Indx KL
CO:WEIOAI
|
$215.46K |
|
ELECTRIC POWER DEVL
MU:FJG
|
$215.37K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Salona Global Medical Device Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,003,258 to 4,003,258, a change of 0 (0.0%).
- Net loss of 15,602,915 reduced equity.
- Other factors increased equity by 15,602,915.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-15.60 Million | -389.76% |
| Other Changes | $15.60 Million | +389.76% |
| Total Change | $- | 0.00% |
Book Value vs Market Value Analysis
This analysis compares Salona Global Medical Device Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.21x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.01x to 0.21x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $1.07 | $0.01 | x |
| 2015-12-31 | $1.20 | $0.01 | x |
| 2016-12-31 | $0.66 | $0.01 | x |
| 2017-12-31 | $0.33 | $0.01 | x |
| 2018-12-31 | $0.33 | $0.01 | x |
| 2019-12-31 | $0.27 | $0.01 | x |
| 2020-12-31 | $0.15 | $0.01 | x |
| 2021-02-28 | $0.15 | $0.01 | x |
| 2021-12-31 | $0.30 | $0.01 | x |
| 2022-02-28 | $0.30 | $0.01 | x |
| 2022-12-31 | $0.28 | $0.01 | x |
| 2023-02-28 | $0.28 | $0.01 | x |
| 2023-12-31 | $0.05 | $0.01 | x |
| 2024-02-29 | $0.05 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Salona Global Medical Device Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -389.76%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -24.91%
- • Asset Turnover: 1.30x
- • Equity Multiplier: 12.05x
- Recent ROE (-389.76%) is below the historical average (-96.40%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -14.01% | -256.89% | 0.04x | 1.49x | $-1.58 Million |
| 2015 | -10.52% | -147.03% | 0.07x | 1.08x | $-6.03 Million |
| 2016 | -44.04% | -219.59% | 0.17x | 1.16x | $-10.63 Million |
| 2017 | -73.01% | -204.61% | 0.35x | 1.03x | $-9.16 Million |
| 2018 | -6.78% | -24.17% | 0.27x | 1.04x | $-1.88 Million |
| 2019 | -26.11% | -664.91% | 0.04x | 1.04x | $-3.24 Million |
| 2020 | -40.16% | 0.00% | 0.00x | 1.98x | $-3.33 Million |
| 2021 | -40.16% | 0.00% | 0.00x | 1.98x | $-3.33 Million |
| 2021 | -33.24% | -23.87% | 0.43x | 3.24x | $-5.69 Million |
| 2022 | -33.24% | -23.87% | 0.43x | 3.24x | $-5.69 Million |
| 2022 | -124.42% | -48.16% | 0.76x | 3.39x | $-20.61 Million |
| 2023 | -124.42% | -48.16% | 0.76x | 3.39x | $-20.61 Million |
| 2023 | -389.76% | -24.91% | 1.30x | 12.05x | $-16.00 Million |
| 2024 | -389.76% | -24.91% | 1.30x | 12.05x | $-16.00 Million |
Industry Comparison
This section compares Salona Global Medical Device Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Salona Global Medical Device Corporation (LNDZF) | $-3.43 Million | -14.01% | N/A | $215.78K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |